"The Australia New Zealand Gynaecological Oncology Group (ANZGOG) is the peak national gynaecological cancer research organisation for Australia and New Zealand. ANZGOG has more than 1,000 members representing clinical, allied health and pure research specialities. ANZGOG clinical trials are conducted at over 50 hospital sites and include both local and global collaborations to ensure the best research is available for women. Our purpose is to improve the outcomes and quality of life for women with gynaecological cancers through conducting and promoting cooperative clinical trials and undertaking multidisciplinary research into causes, prevention and treatments of gynaecological cancer."

During the past decade, Australia New Zealand Gynaecological Oncology Trials Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Australia New Zealand Gynaecological Oncology Trials Group" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Australia New Zealand Gynaecological Oncology Trials Group" are "Ovarian Cancer" (3 trials), "Primary Peritoneal Cavity Cancer" (3 trials) and "Endometrial Cancer" (2 trials). Many other conditions were trialed in "Australia New Zealand Gynaecological Oncology Trials Group" in a lesser frequency.

Most popular intervention types in "Australia New Zealand Gynaecological Oncology Trials Group" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "alvocidib" (1 trials), "carboplatin" (1 trials), "cetuximab" (1 trials), "cisplatin" (1 trials) and "docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Australia New Zealand Gynaecological Oncology Trials Group" are 5 trials for "Female" genders.

Currently, there are NaN active trials in "Australia New Zealand Gynaecological Oncology Trials Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Australia New Zealand Gynaecological Oncology Trials Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Australia New Zealand Gynaecological Oncology Trials Group, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".